Fiserv, Inc. (FISV)

Fiserv's stock has rallied hard into the new analyst cycle. The price of $63.32 is up 38.77% over one month and 8.42% over one week, after a 12.46% gain in the first session following the November 3, 2026 report, when adjusted EPS of $1.75 beat the $1.71 estimate. On November 4, Argus Research upgraded the stock to Buy from Hold, while UBS, Citigroup, JP Morgan, TD Cowen and Barclays kept their ratings unchanged. The move has pushed the stock close to its 52-week high of $70.41 and well above its moving averages, which leaves the stock stretched on short-term measures even as its longer-term trend is firmly up.

The stock's rally was tied to the November 3, 2026 earnings report. Adjusted EPS of $1.75 beat the analysts' estimate of $1.71 by 2.34%, and the share price rose 12.46% in the first trading session after the report. On November 4, Argus Research upgraded the stock to Buy from Hold, while UBS, Citigroup, JP Morgan, TD Cowen and Barclays kept their existing ratings. The one-week gain of 8.42% and the one-month gain of 38.77% show how quickly the price has re-rated since then.

The beat in November follows a mixed run. Of the last six reports, four beat the EPS estimate, but three of those four beats were followed by a lower share price in the first session. The August 6, 2026 report missed by 3.66% and left the price flat, and the October 29, 2025 report missed by 23.02% and was followed by a 44.04% fall. The November reaction is therefore notable because it is the one clear case in this set where a beat was followed by a strong gain.

The company reports a net profit margin of 16.42%, an operating margin of 27.34% and a return on equity of 13.48%, with a debt-to-equity ratio of 0.01. Against that, analysts expect revenue for this fiscal year to shrink 1.4% to $19.5B, so the revenue outlook is weaker than the latest quarter alone suggests.

Over the last 18 months, insiders made open-market purchases worth $4.5M across recent filings, against sales worth $1.3M in two transactions. Insider sales are often planned in advance or made to cover tax on vesting shares, so the purchases are the more informative part of that record.

The base case is that the stock's trend holds while the earnings picture stabilises. Fiserv's trend is up, with the price above its 50-day and 200-day moving averages ($49.75 and $54.51), and the MACD line is positive. But the 14-day RSI of 82.0 is in overbought territory, so the stock has run ahead of its averages and a pause or pullback would be normal after a move this fast. Analysts expect adjusted EPS for 2026 to shrink 16.0% to $7.26 and then grow 9.9% to $7.98 in 2027, so the next leg depends on whether the company delivers on that recovery. The median 12-month analyst target is $59.50, which sits 6.0% below the price, and the range runs from $40.00 to $106.00. Upside beyond the 52-week high would need further beats and rating upgrades; a miss or a fall through the 20-day EMA would put the moving averages back in focus.

Support sits at the 20-day EMA of $54.71, which is the nearest level below the price, followed by the 200-day SMA at $54.51, the 50-day SMA at $49.75 and the 52-week low at $43.87. The 20-day EMA and 200-day SMA sit almost on top of each other, so a fall toward them would meet two averages at once. Resistance sits at the 52-week high of $70.41, the only level above the price. A rise through that high would mark a new 52-week peak.